Ocular Therapeutix grants new HR chief options for 75,000 shares, 25,000 RSUs

Ocular Therapeutix Inc

Ocular Therapeutix Inc

OCUL

0.00
  • Ocular Therapeutix granted inducement equity awards to new SVP, Head of HR Amy Ricca, effective May 11, 2026.
  • Package includes non-statutory stock options for 75,000 shares with exercise price USD 9.28, matching closing price on grant date.
  • Also includes restricted stock units covering 25,000 shares, vesting in equal annual installments over three years.
  • Stock options carry a 10-year term, vesting 25% after one year with remainder vesting monthly over next three years, subject to continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief on May 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.